DANBURY, Conn., Jan. 6, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today announced that Dr. Errol De Souza, President and CEO of Biodel, will present a corporate update at the 30th Annual JPMorgan Healthcare Conference on Thursday, January 12, 2012 at 1:00 p.m. Pacific Time ( 4:00 p.m. Eastern Time). The JPMorgan Healthcare Conference will be held January 9-12, 2012, at the Westin St. Francis Hotel in San Francisco, California. Interested parties may access the presentation in the investor relations section of Biodel's website at www.biodel.com which will link to a live webcast to be archived for 90 days. About Biodel Inc. Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles. For further information regarding Biodel, please visit the company's website at www.biodel.com. BIOD-G CONTACT: Seth Lewis, +1-646-378-2952 SOURCE Biodel Inc.